closed at ₹547.75 on the on Wednesday, gaining ₹8.85 or 1.64 per cent for the day, with the stock touching an intraday high of ₹557.85. Traded volume stood at 7.24 lakh shares, worth ₹39.82 crore, with 40.18 per cent of shares resulting in delivery.
The Union Cabinet on March 10 approved the extension of the Jal Jeevan Mission (JJM) through December 2028, with a total enhanced outlay of ₹8.69 lakh crore, including central assistance of ₹3.59 lakh crore — up from ₹2.08 lakh crore sanctioned in 2019-20.
The mission’s focus shifts from infrastructure creation to sustainable service delivery, with stricter state-level accountability built into the revised framework dubbed JJM 2.0.
KEC International carries approximately ₹1,600 crore of JJM-linked orders in its ₹39,300 crore backlog, making it a direct beneficiary of fresh tendering expected under the renewed mandate. The market read the Cabinet approval as a signal that order flows — stalled following a funding pause in late 2025 amid corruption controversies — are likely to resume.
Despite Wednesday’s gain, the stock remains under significant pressure on a longer horizon. It is down 19.15 per cent over one year and 25.90 per cent year-to-date, against the Nifty Smallcap 100’s 8.57 per cent and -7.81 per cent returns respectively over the same periods.
Its 52-week high was ₹947.00, hit in June 2025, while its 52-week low of ₹520.20 was recorded just a day earlier, on March 9. The current P/E stands at 21.06.
Execution risks persist. Payment delays from state governments and concerns over the effectiveness of the new scheme-based disbursement model will be closely watched as JJM 2.0 rolls out.